Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/19/24 16:31 | 11/18/24 | RVNC | Health | Drug | Pharmaceutical Preparations | Hollander David | TN | O | CMO,Glob | 1 | S | -16 | 4.17 | 0 | -4 | 105 | D | |||||||||||||||
4/17/24 16:34 | 4/16/24 | RVNC | Health | Drug | Pharmaceutical Preparations | Jordan Erica | TN | O | Chief Co | 1 | S | -9 | 3.80 | 0 | -2 | 115 | D | |||||||||||||||
3/19/24 18:45 | 3/18/24 | RVNC | Health | Drug | Pharmaceutical Preparations | Sjuts Dustin S | TN | O | P | 1 | S | -46 | 5.04 | 0 | -9 | 168 | D | |||||||||||||||
3/19/24 18:44 | 3/18/24 | RVNC | Health | Drug | Pharmaceutical Preparations | Moxie Dwight | TN | O | CLO,GC | 2 | S.m | -654 | 15.21 | 0 | -43 | 138 | D | |||||||||||||||
3/19/24 18:44 | 3/18/24 | RVNC | Health | Drug | Pharmaceutical Preparations | Schilke Tobin | TN | O | CFO | 1 | S | -47 | 5.04 | 0 | -9 | 193 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |